Company Overview
Company Name
Galectin Therapeutics
Address
United States
Website
galectintherapeutics.comPhone
(678) 620-3186Approx. Annual Revenue
$9.0M
Employees
50
Established
2010
About Galectin Therapeutics
Galectin Therapeutics is a US-based company with approximately 11 employees. The company is focused on developing proprietary galectin inhibitors and discovering new treatments for diseases such as non-alcoholic steatohepatitis (NASH) cirrhosis, fibrosis, and cancer. Their lead drug candidate, belapectin, is currently in clinical trials for NASH cirrhosis.
More Companies in District of Columbia
Browse all companies in District of Columbia →